PCCW Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

PCCW şirketinin toplam hissedar öz sermayesi HK$6.7B ve toplam borcu HK$56.1B olup, bu da borç-öz sermaye oranını 840.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla HK$96.0B ve HK$89.3B dir. PCCW 'in FAVÖK'ü HK$5.1B faiz karşılama oranı 2 dur. Şirketin HK$2.1B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

840.8%

Borç/özkaynak oranı

HK$56.11b

Borç

Faiz karşılama oranı	2x
Nakit	HK$2.14b
Eşitlik	HK$6.67b
Toplam yükümlülükler	HK$89.30b
Toplam varlıklar	HK$95.98b

Son finansal sağlık güncellemeleri

Recent updates

PCCW Limited's (HKG:8) Share Price Matching Investor Opinion

Jan 21

Is PCCW (HKG:8) Using Too Much Debt?

Nov 26

Some Confidence Is Lacking In PCCW Limited's (HKG:8) P/S

Aug 28

PCCW (HKG:8) Is Due To Pay A Dividend Of HK$0.2848

Jun 01

PCCW (HKG:8) Has A Somewhat Strained Balance Sheet

Apr 25

PCCW (HKG:8) Will Pay A Dividend Of HK$0.2848

Apr 03

Some Shareholders Feeling Restless Over PCCW Limited's (HKG:8) P/S Ratio

Mar 21

PCCW (HKG:8) Is Paying Out A Dividend Of HK$0.2848

Feb 26

Does PCCW (HKG:8) Have A Healthy Balance Sheet?

Nov 14

PCCW's (HKG:8) Upcoming Dividend Will Be Larger Than Last Year's

Aug 06

Is PCCW (HKG:8) Using Too Much Debt?

Aug 04

PCCW (HKG:8) Takes On Some Risk With Its Use Of Debt

Oct 24

PCCW (HKG:8) Has A Somewhat Strained Balance Sheet

Apr 19

Is PCCW Limited (HKG:8) Expensive For A Reason? A Look At Its Intrinsic Value

Dec 16

PCCW (HKG:8) Has No Shortage Of Debt

Sep 16

The Returns On Capital At PCCW (HKG:8) Don't Inspire Confidence

Jul 20

Shareholders May Not Be So Generous With PCCW Limited's (HKG:8) CEO Compensation And Here's Why

Apr 30

PCCW (HKG:8) May Have Issues Allocating Its Capital

Apr 06

Who Has Been Buying PCCW Limited (HKG:8) Shares?

Mar 19

Does PCCW (HKG:8) Have A Healthy Balance Sheet?

Mar 01

PCCW Limited Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

Feb 08

How Much Of PCCW Limited (HKG:8) Do Insiders Own?

Jan 19

Should We Be Excited About The Trends Of Returns At PCCW (HKG:8)?

Dec 22

Is PCCW (HKG:8) A Risky Investment?

Nov 30

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 8 'nin kısa vadeli varlıkları ( HK$14.2B ) kısa vadeli yükümlülüklerini ( HK$23.5B ) kapsamıyor.

Uzun Vadeli Yükümlülükler: 8 'un kısa vadeli varlıkları ( HK$14.2B ) uzun vadeli yükümlülüklerini ( HK$65.8B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 8 'nin net borç/öz sermaye oranı ( 808.7% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 8 şirketinin borç/öz sermaye oranı son 5 yılda 283.4% seviyesinden 840.8% seviyesine yükseldi.

Borç Kapsamı: 8 'nin borcu işletme nakit akışı ( 22.7% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 8 'in borcuna ilişkin faiz ödemeleri EBIT ( 2 x kapsam) tarafından iyi karşılanmıyor.

Bilanço

Sağlıklı şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/01/29 05:56
Gün Sonu Hisse Fiyatı	2025/01/28 00:00
Kazançlar	2024/06/30
Yıllık Kazançlar	2023/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

PCCW Limited 15 Bu analistlerden 2, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Anand Ramachandran	Barclays
Allan NG	BOCI Research Ltd.
Feiyun Fang	Citigroup Inc

PCCW Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is PCCW (HKG:8) Using Too Much Debt?

PCCW (HKG:8) Has A Somewhat Strained Balance Sheet

Does PCCW (HKG:8) Have A Healthy Balance Sheet?

Is PCCW (HKG:8) Using Too Much Debt?

PCCW (HKG:8) Takes On Some Risk With Its Use Of Debt

PCCW (HKG:8) Has A Somewhat Strained Balance Sheet

Recent updates

PCCW Limited's (HKG:8) Share Price Matching Investor Opinion

Is PCCW (HKG:8) Using Too Much Debt?

First half 2024 earnings released: HK$0.06 loss per share (vs HK$0.063 loss in 1H 2023)

Some Confidence Is Lacking In PCCW Limited's (HKG:8) P/S

First half dividend of HK$0.098 announced

First half 2024 earnings released: HK$0.06 loss per share (vs HK$0.063 loss in 1H 2023)

PCCW Limited to Report First Half, 2024 Results on Jul 26, 2024

Acting Group MD recently sold HK$3.4m worth of stock

PCCW Limited Announces Resignation of Wang Fang as Non-Executive Director

PCCW (HKG:8) Is Due To Pay A Dividend Of HK$0.2848

PCCW Limited Approves Final Dividend for the Year Ended 31 December 2023

Upcoming dividend of HK$0.28 per share

PCCW (HKG:8) Has A Somewhat Strained Balance Sheet

PCCW (HKG:8) Will Pay A Dividend Of HK$0.2848

Full year 2023 earnings: EPS and revenues miss analyst expectations

Some Shareholders Feeling Restless Over PCCW Limited's (HKG:8) P/S Ratio

PCCW (HKG:8) Is Paying Out A Dividend Of HK$0.2848

First half dividend of HK$0.28 announced

PCCW Limited, Annual General Meeting, May 30, 2024

PCCW Limited Proposes Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024

PCCW Limited to Report Fiscal Year 2023 Results on Feb 23, 2024

Executive Chairman recently bought HK$5.7m worth of stock

Executive Chairman recently bought HK$3.3m worth of stock

Does PCCW (HKG:8) Have A Healthy Balance Sheet?

Executive Chairman recently bought HK$7.9m worth of stock

Executive Chairman recently bought HK$5.8m worth of stock

First half 2023 earnings released: HK$0.063 loss per share (vs HK$0.025 loss in 1H 2022)

Acting Group MD recently sold HK$2.0m worth of stock

Upcoming dividend of HK$0.098 per share at 9.9% yield

PCCW's (HKG:8) Upcoming Dividend Will Be Larger Than Last Year's

Is PCCW (HKG:8) Using Too Much Debt?

PCCW Limited Appoints Tang Yongbo as Non-Executive Director, Deputy Chairman of the Board and Member of the Executive Committee of the Board

First half 2023 earnings released: HK$0.063 loss per share (vs HK$0.011 loss in 1H 2022)

PCCW Limited to Report First Half, 2023 Results on Aug 03, 2023

PCCW Limited Approves to Declare A Final Dividend in Respect of the Year Ended 31 December 2022

Upcoming dividend of HK$0.28 per share at 9.5% yield

Full year 2022 earnings: EPS and revenues miss analyst expectations

PCCW Limited to Report Fiscal Year 2022 Results on Feb 24, 2023

Price target decreased to HK$4.58

Price target decreased to HK$4.68

Less than half of directors are independent

PCCW (HKG:8) Takes On Some Risk With Its Use Of Debt

Consensus forecasts updated

Upcoming dividend of HK$0.096 per share

Now 20% undervalued after recent price drop

First half 2022 earnings released: HK$0.011 loss per share (vs HK$0.041 loss in 1H 2021)

Pccw Limited Announces Appointment of Lars Eric Nils Rodert as A Member of the Nomination Committee

PCCW Limited to Report First Half, 2022 Results on Aug 12, 2022

Less than half of directors are independent

PCCW Limited Announces Resignation of David Lawrence Herzog as an Independent Non-Executive Director and Member of Each of the Nomination Committee, Remuneration Committee and Regulatory Compliance Committee of the Board

Consensus forecasts updated

PCCW Limited Announces Mai Yanzhou Resigns as Non-Executive Director, with Effect from May 30, 2022

PCCW Limited Approves Final Dividend for the Year Ended December 31, 2022

Upcoming dividend of HK$0.28 per share

PCCW (HKG:8) Has A Somewhat Strained Balance Sheet

Full year 2021 earnings: EPS exceeds analyst expectations

Consensus forecasts updated

PCCW Limited Proposes Final Dividend in Respect of the Year Ended December 31, 2021

PCCW Limited Announces Board and Executive Committee Changes

Full year 2021 earnings: EPS exceeds analyst expectations

PCCW Limited, Annual General Meeting, May 13, 2022

PCCW Limited to Report Fiscal Year 2021 Results on Feb 24, 2022

Is PCCW Limited (HKG:8) Expensive For A Reason? A Look At Its Intrinsic Value

Funds affiliated with investment management platform of DigitalBridge Group, Inc. (NYSE:DBRG) completed the acquisition of PCCW Powerbase Data Center Services (HK) Ltd. and PCCW Solutions Data Centers Malaysia Sdn. Bhd. from PCCW Limited (SEHK:8).

Group General Counsel & Company Secretary Bernadette Mak Lomas has left the company

PCCW (HKG:8) Has No Shortage Of Debt

Vantage Data Centers Management Company, LLC agreed to acquire Data Center Portfolio of PCCW Limited (SEHK:8).

First half 2021 earnings released: HK$0.041 loss per share (vs HK$0.076 loss in 1H 2020)

Upcoming dividend of HK$0.094 per share